Logo image of DHT-UN.CA

DRI HEALTHCARE TRUST (DHT-UN.CA) Stock Price, Forecast & Analysis

Canada - Toronto Stock Exchange - TSX:DHT-UN - CA23344H1091

16.46 CAD
0 (0%)
Last: 12/5/2025, 7:00:00 PM

DHT-UN.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap907.11M
Revenue(TTM)192.69M
Net Income(TTM)-52.23M
Shares55.11M
Float54.60M
52 Week High17.04
52 Week Low10.7
Yearly DividendN/A
Dividend Yield4.57%
EPS(TTM)2.25
PE7.32
Fwd PE7.15
Earnings (Next)03-02 2026-03-02/amc
IPO2021-02-11
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


DHT-UN.CA short term performance overview.The bars show the price performance of DHT-UN.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20 25

DHT-UN.CA long term performance overview.The bars show the price performance of DHT-UN.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of DHT-UN.CA is 16.46 CAD. In the past month the price increased by 7.37%. In the past year, price increased by 33.17%.

DRI HEALTHCARE TRUST / DHT-UN Daily stock chart

DHT-UN.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.81 3.56B
CRON.CA CRONOS GROUP INC 23.07 1.32B
TLRY.CA TILRAY BRANDS INC N/A 1.18B
DHT-U.CA DRI HEALTHCARE TRUST 5.26 652.50M
GUD.CA KNIGHT THERAPEUTICS INC N/A 600.70M
WEED.CA CANOPY GROWTH CORP N/A 589.54M
NGEN.CA NERVGEN PHARMA CORP N/A 426.65M
CPH.CA CIPHER PHARMACEUTICALS INC 15.87 370.40M
ACB.CA AURORA CANNABIS INC N/A 359.25M
OGI.CA ORGANIGRAM GLOBAL INC N/A 304.93M
HITI.CA HIGH TIDE INC N/A 304.50M
TSND.CA TERRASCEND CORP N/A 272.50M

DRI HEALTHCARE TRUST / DHT-UN.CA FAQ

What does DRI HEALTHCARE TRUST do?

DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company acquires more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The firm is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Galderma, and others.


Can you provide the latest stock price for DRI HEALTHCARE TRUST?

The current stock price of DHT-UN.CA is 16.46 CAD.


How is the ChartMill rating for DRI HEALTHCARE TRUST?

DHT-UN.CA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


DHT-UN.CA Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to DHT-UN.CA. When comparing the yearly performance of all stocks, DHT-UN.CA is one of the better performing stocks in the market, outperforming 72.03% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating